Jeffrey Slovin - DENTSPLY SIRONA Insider

XRAY -- USA Stock  

USD 44.72  0.63  1.39%

CEO, Director
Mr. Jeffrey T. Slovin is Chief Executive Officer, Director of the Company. Mr. Slovin currently serves as the Companys Chief Executive Officer and as a Director on the Companys Board of Directors. Formerly, Mr. Slovin served as Sirona Dental Systems, Inc.s Chief Executive Officer from February 2013 through February 2016 and as its President from September 20, 2010 through February 28, 2016. Prior to September 20, 2010, Mr. Slovin served as Sirona Dental Systems, Inc.s Executive Vice President and Chief Operating Officer of U.S. Operations from June 2006 through September 2010. Prior to that time, Mr. Slovin was Chief Executive Officer of Schick since June 2004 and Schicks President from December 1999 to June 2004. He has also served as a Schick Director since December 1999. In addition, from November 2001 to June 15, 2004, Mr. Slovin served as Schicks Chief Operating Officer. From 1999 to November 2001, Mr. Slovin was a Managing Director of Greystone Co., Inc. From 1996 to 1999, he served in various executive capacities at Sommerset Investment Capital LLC, including Managing Director, and as President of Sommerset Realty Investment Corporationration During 1995, Mr. Slovin was a Manager at Fidelity Investments Co. From 1991 to 1994, he was Chief Financial Officer of SportsLab U.S.A. Corporationration and, from 1993 to 1994, was also President of Sports and Entertainment Inc. From 1987 to 1991, Mr. Slovin was an associate at Bear Stearns Co., specializing in mergers and acquisitions and corporate finance. Mr. Slovin is currently a member of the Board of Fellows of the Harvard School of Dental Medicine, and a member of the World Presidents Organization
Age: 51  CEO Since 2016  MBA    
717-845-7511  http://www.dentsplysirona.com
Slovin holds an M.B.A. degree from Harvard Business School.

Jeffrey Slovin Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 2.88 % which means that it generated profit of $2.88 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (20.57) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 1.67 B in liabilities with Debt to Equity (D/E) ratio of 24.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. DENTSPLY SIRONA has Current Ratio of 2.19 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 11 records

CEO Since

Michael McMullenAgilent Technologies
2015
Gary HuffLaboratory Corporation of Ameri
2017
Rui ArashiyamaChina Cord Blood Corporation
N/A
Dow WilsonVarian Medical Systems
2012
David CordaniCigna Corporation
2009
Yue DengChina Cord Blood Corporation
N/A
Ting ZhengChina Cord Blood Corporation
2017
James BoyleLaboratory Corporation of Ameri
N/A
Thomas PikeIQVIA Holdings
2016
John RatliffLaboratory Corporation of Ameri
N/A
Deborah TannerLaboratory Corporation of Ameri
2015

Entity Summary

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania. DENTSPLY SIRONA operates under Medical Instruments Supplies classification in USA and traded on NASDAQ. It employs 16100 people.DENTSPLY SIRONA (XRAY) is traded on NASDAQ in USA. It is located in 221 West Philadelphia Street and employs 16,100 people.

DENTSPLY SIRONA Leadership Team

Maureen MacInnis, President, MBA
Thomas Jetter, Director, Ph.D
Ulrich Michel, President
Rainer Berthan, President
Paula Cholmondeley, Director
John Sweeney, President
Francis Lunger, Director
Robert Size, SVP, MBA
Christopher Clark, CFO, MBA
Harry Kraemer, Director
Deborah Rasin, President
Michael Coleman, Director
Betsy Holden, Director
David Beecken, Director
Leslie Varon, Director
Eric Brandt, Director
Donald Casey, CEO, MBA
Derek Leckow, VP
Willie Deese, Director
Nicholas Alexos, President, MBA
Justin McCarthy, Executive
Albert Sterkenburg, President, Ph.D
Keith Ebling, President, MBA
John Miles, Director
William Hecht, Director
Michael Alfano, Director, Ph.D
James Mosch, COO, MBA
Jonathan Friedman, President
Mark Thierer, CEO
John Miclot, Director
Bret Wise, Chairman
Arthur Kowaloff, Director
Jeffrey Slovin, CEO, MBA

Stock Performance Indicators

Did you try this?

Run Equity Search Now
   

Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
All  Next Launch Equity Search

Also Currentnly Active

Purchased over 100 shares of
few hours ago
Traded for 25.35
Purchased over 500 shares of
few hours ago
Traded for 5.66
Purchased few shares of
few hours ago
Traded for 1188.8199
See also Your Current Watchlist. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.